Clinical Trials List
Protocol Number156-TWA-1101(i)
2012-01-01 - 2013-03-31
Phase III
Terminated3
-
Trial Applicant
STATPLUS, INC.
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 曾春典 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Po-Sheng Chen Division of Cardiovascular Diseases
- Chih-Hsin Hsu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
88 participants
-
Global
0 participants
